BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36603782)

  • 1. Role of herbal medicine and gut microbiota in the prevention and treatment of obesity.
    Zhang Q; Bai Y; Wang W; Li J; Zhang L; Tang Y; Yue S
    J Ethnopharmacol; 2023 Apr; 305():116127. PubMed ID: 36603782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xiexin Tang ameliorates dyslipidemia in high-fat diet-induced obese rats via elevating gut microbiota-derived short chain fatty acids production and adjusting energy metabolism.
    Xiao S; Zhang Z; Chen M; Zou J; Jiang S; Qian D; Duan J
    J Ethnopharmacol; 2019 Sep; 241():112032. PubMed ID: 31220598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic and vascular protective effects of olive (Olea europaea L.) leaf extract in diet-induced obesity in mice are related to the amelioration of gut microbiota dysbiosis and to its immunomodulatory properties.
    Vezza T; Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Romero M; Sánchez M; Toral M; Martín-García B; Gómez-Caravaca AM; Arráez-Román D; Segura-Carretero A; Micol V; García F; Utrilla MP; Duarte J; Rodríguez-Cabezas ME; Gálvez J
    Pharmacol Res; 2019 Dec; 150():104487. PubMed ID: 31610229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated omics analysis unraveled the microbiome-mediated effects of Yijin-Tang on hepatosteatosis and insulin resistance in obese mouse.
    Lee JE; Lee SM; Jung J
    Phytomedicine; 2020 Dec; 79():153354. PubMed ID: 32992082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the Gut Microbiota after the Use of Herbal Medicines in Overweight and Obese Individuals: A Systematic Review.
    Huang M; Cople-Rodrigues CDS; Waitzberg DL; Rocha IMGD; Curioni CC
    Nutrients; 2023 May; 15(9):. PubMed ID: 37432344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jamun (Eugenia jambolana Lam.) Fruit Extract Prevents Obesity by Modulating the Gut Microbiome in High-Fat-Diet-Fed Mice.
    Xu J; Liu T; Li Y; Liu W; Ding Z; Ma H; Seeram NP; Mu Y; Huang X; Li L
    Mol Nutr Food Res; 2019 May; 63(9):e1801307. PubMed ID: 30762938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of traditional Chinese medicine affecting gut microbiota in obesity.
    Li D; Tang W; Wang Y; Gao Q; Zhang H; Zhang Y; Wang Y; Yang Y; Zhou Y; Zhang Y; Li H; Li S; Zhao H
    Front Endocrinol (Lausanne); 2023; 14():1149751. PubMed ID: 36936157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota mediates the effects of curcumin on enhancing Ucp1-dependent thermogenesis and improving high-fat diet-induced obesity.
    Han Z; Yao L; Zhong Y; Xiao Y; Gao J; Zheng Z; Fan S; Zhang Z; Gong S; Chang S; Cui X; Cai J
    Food Funct; 2021 Jul; 12(14):6558-6575. PubMed ID: 34096956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stronger anti-obesity effect of white ginseng over red ginseng and the potential mechanisms involving chemically structural/compositional specificity to gut microbiota.
    Zhou SS; Auyeung KK; Yip KM; Ye R; Zhao ZZ; Mao Q; Xu J; Chen HB; Li SL
    Phytomedicine; 2020 Aug; 74():152761. PubMed ID: 31005370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?
    Chen F; Wen Q; Jiang J; Li HL; Tan YF; Li YH; Zeng NK
    J Ethnopharmacol; 2016 Feb; 179():253-64. PubMed ID: 26723469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions Between Gut Microbiota, Host, and Herbal Medicines: A Review of New Insights Into the Pathogenesis and Treatment of Type 2 Diabetes.
    Zheng Y; Gou X; Zhang L; Gao H; Wei Y; Yu X; Pang B; Tian J; Tong X; Li M
    Front Cell Infect Microbiol; 2020; 10():360. PubMed ID: 32766169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seabuckthorn (
    Guo C; Han L; Li M; Yu L
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31968607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats.
    Zhang X; Zhao Y; Xu J; Xue Z; Zhang M; Pang X; Zhang X; Zhao L
    Sci Rep; 2015 Sep; 5():14405. PubMed ID: 26396057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice.
    Guo J; Zhang M; Wang H; Li N; Lu Z; Li L; Hui S; Xu H
    J Food Biochem; 2022 May; 46(5):e14063. PubMed ID: 35128673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yanning Syrup ameliorates the lipopolysaccharide-induced inflammation: Adjusting the gut microbiota, short-chain fatty acids, and the CD4
    Wei D; Ma P; Fan Q; Yu H; Peng Y; Li X
    J Ethnopharmacol; 2022 Jan; 283():114729. PubMed ID: 34634365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary betaine prevents obesity through gut microbiota-drived microRNA-378a family.
    Du J; Zhang P; Luo J; Shen L; Zhang S; Gu H; He J; Wang L; Zhao X; Gan M; Yang L; Niu L; Zhao Y; Tang Q; Tang G; Jiang D; Jiang Y; Li M; Jiang A; Jin L; Ma J; Shuai S; Bai L; Wang J; Zeng B; Wu D; Li X; Zhu L
    Gut Microbes; 2021; 13(1):1-19. PubMed ID: 33550882
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Xiang JY; Chi YY; Han JX; Kong P; Liang Z; Wang D; Xiang H; Xie Q
    Food Funct; 2022 Mar; 13(5):2832-2845. PubMed ID: 35179169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molokhia leaf extract prevents gut inflammation and obesity.
    Lee HB; Oh MJ; Do MH; Kim YS; Park HY
    J Ethnopharmacol; 2020 Jul; 257():112866. PubMed ID: 32302714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Obesity for the Prevention of Chronic Cardiovascular Disease Through Gut Microbiota-Herb Interactions: An Opportunity for Traditional Herbs.
    Chen F; Jiang J; Tian DD; Wen Q; Li YH; Zhang JQ; Cheng C; Wang T
    Curr Pharm Des; 2017; 23(8):1142-1152. PubMed ID: 27758701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota: a potential target for traditional Chinese medicine intervention in coronary heart disease.
    Cheng TY; Li JX; Chen JY; Chen PY; Ma LR; Zhang GL; Yan PY
    Chin Med; 2021 Oct; 16(1):108. PubMed ID: 34686199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.